Hyderabad startup makes world-first breakthrough in liver treatment

Hyderabad has made a remarkable breakthrough in biotechnology. Tulsi Therapeutics, a startup nurtured at ASPIRE-BioNEST at the University of Hyderabad, has achieved the world’s first successful animal trial using a new stem cell-exosome therapy for chronic liver failure. The innovative product, Tulsi-28X, is a pioneering treatment derived from Wharton’s Jelly stem cells and their exosomes. […]

The post Hyderabad startup makes world-first breakthrough in liver treatment first appeared on Telangana Tribune.

News